alliin has been researched along with 1,3-dichloro-2-propanol in 1 studies
| Studies (alliin) | Trials (alliin) | Recent Studies (post-2010) (alliin) | Studies (1,3-dichloro-2-propanol) | Trials (1,3-dichloro-2-propanol) | Recent Studies (post-2010) (1,3-dichloro-2-propanol) |
|---|---|---|---|---|---|
| 149 | 4 | 71 | 86 | 0 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, B; Fang, B; Guan, S; Li, T; Liu, M; Lu, J; Meng, Z; Sun, M | 1 |
1 other study(ies) available for alliin and 1,3-dichloro-2-propanol
| Article | Year |
|---|---|
Alliin attenuates 1, 3-dichloro-2-propanol-induced lipogenesis in HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway.
Topics: alpha-Chlorohydrin; AMP-Activated Protein Kinases; Cell Survival; Cholesterol; Cysteine; Enzyme Activation; Gene Expression Regulation; Hep G2 Cells; Humans; Hypolipidemic Agents; Lipid Metabolism; Signal Transduction; Sterol Regulatory Element Binding Proteins; Triglycerides | 2018 |